The Valley Desk

NCT01609790 · Interventional trial

Bevacizumab With or Without Trebananib in Treating Patients With Recurrent Brain Tumors

Overall registry status Completed

Phase 2

Conditions Giant Cell Glioblastoma, Glioblastoma, Gliosarcoma, Oligodendroglioma, Recurrent Brain Neoplasm, Recurrent Glioblastoma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov